Exelixis (EXEL) director awarded 8,367 RSUs vesting in 2027

Q: When do the newly granted RSUs for Exelixis (EXEL) director vest?

The 8,367 RSUs vest 100% on May 27, 2027 , according to the filing. Vesting is contingent on the director’s continuous service with Exelixis through that date, meaning no shares are delivered before the full vesting date.

Q: Are the Exelixis (EXEL) RSUs granted to the director equivalent to common stock now?

Each RSU is described as the economic equivalent of one share of Exelixis common stock. However, actual shares will only be issued when the RSUs vest on May 27, 2027, assuming the director continues in service until that date.

Q: Is this Exelixis (EXEL) Form 4 a market transaction or compensation grant?

The Form 4 reports a compensation-related grant coded as an acquisition (A), not a market trade. The director did not buy or sell shares in the open market; instead, he received RSUs under the company’s 2017 Equity Incentive Plan.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

WYSZOMIERSKI JACK L reported acquisition or exercise transactions in this Form 4 filing.

Exelixis, Inc. director Jack L. Wyszomierski received a grant of 8,367 restricted stock units, each equal to one share of common stock, under the 2017 Equity Incentive Plan. The RSUs vest in full on May 27, 2027, subject to continuous service, bringing his reported holdings to 288,309 shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider WYSZOMIERSKI JACK L

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	8,367	$0.00	--

Holdings After Transaction: Common Stock — 288,309 shares (Direct, null)

Footnotes (1)

Represents restricted stock units ("RSUs") granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. Each RSU is the economic equivalent of one share of Exelixis, Inc. common stock ("Common Stock"). The RSUs will vest as to 100% of the shares subject to the RSU award on May 27, 2027, subject to the Reporting Person's continuous service through that date. Includes 8,367 shares of Common Stock that will be issued to the Reporting Person upon vesting of RSUs.

Key Figures

RSUs granted: 8,367 units Shares after transaction: 288,309 shares RSU vesting date: May 27, 2027 +1 more

4 metrics

RSUs granted 8,367 units Restricted stock units granted on May 27, 2026

Shares after transaction 288,309 shares Total beneficial ownership following RSU grant

RSU vesting date May 27, 2027 100% of RSU award vests on this date

Grant price per share $0.0000 per share Reported transaction price for RSU grant

Key Terms

restricted stock units ("RSUs"), 2017 Equity Incentive Plan, economic equivalent, continuous service

4 terms

restricted stock units ("RSUs") financial

"Represents restricted stock units ("RSUs") granted to the Reporting Person on the Transaction Date"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

2017 Equity Incentive Plan financial

"pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan"

economic equivalent financial

"Each RSU is the economic equivalent of one share of Exelixis, Inc. common stock"

continuous service financial

"subject to the Reporting Person's continuous service through that date"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

05/29/2026 - 05:43 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WYSZOMIERSKI JACK L

(Last)

(First)

(Middle)

C/O EXELIXIS, INC.

1851 HARBOR BAY PARKWAY

(Street)

ALAMEDA

CALIFORNIA

94502

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
EXELIXIS, INC. [ EXEL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/27/2026		A		8,367⁽¹⁾	A	$0	288,309⁽²⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents restricted stock units ("RSUs") granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. Each RSU is the economic equivalent of one share of Exelixis, Inc. common stock ("Common Stock"). The RSUs will vest as to 100% of the shares subject to the RSU award on May 27, 2027, subject to the Reporting Person's continuous service through that date.

2. Includes 8,367 shares of Common Stock that will be issued to the Reporting Person upon vesting of RSUs.

Remarks:

	/s/ Nina Ayer, Attorney in Fact	05/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Exelixis (EXEL) director Jack Wyszomierski receive in this Form 4?

Jack L. Wyszomierski received a grant of 8,367 restricted stock units of Exelixis common stock. These RSUs are equity-based compensation awarded under the company’s 2017 Equity Incentive Plan and are not an open-market share purchase or sale.

When do the newly granted RSUs for Exelixis (EXEL) director vest?

The 8,367 RSUs vest 100% on May 27, 2027, according to the filing. Vesting is contingent on the director’s continuous service with Exelixis through that date, meaning no shares are delivered before the full vesting date.

How many Exelixis (EXEL) shares does the director hold after this RSU grant?

After the RSU grant, the director is reported to beneficially own 288,309 shares of Exelixis common stock. This total includes the 8,367 shares that will be issued upon the future vesting of the restricted stock units described in the filing.

Are the Exelixis (EXEL) RSUs granted to the director equivalent to common stock now?

Each RSU is described as the economic equivalent of one share of Exelixis common stock. However, actual shares will only be issued when the RSUs vest on May 27, 2027, assuming the director continues in service until that date.

Is this Exelixis (EXEL) Form 4 a market transaction or compensation grant?

The Form 4 reports a compensation-related grant coded as an acquisition (A), not a market trade. The director did not buy or sell shares in the open market; instead, he received RSUs under the company’s 2017 Equity Incentive Plan.